Trials / Sponsors / JHL Biotech, Inc.
JHL Biotech, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study to Compare the Bioequivalence and Safety of JHL1101 and Rituximab in CD20 Positive B Cell Lymphoma Pat B Cell Lymphoma | Phase 1 | 2018-11-16 |
| Terminated | A Study to Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated D Diffuse Large B-Cell Lymphoma | Phase 3 | 2018-11-13 |
| Completed | A Study to Compare the Pharmacokinetics of JHL1149 and Bevacizumab (Avastin) in Healthy Male Volunteers Healthy Male Subjects | Phase 1 | 2018-03-24 |
| Completed | A Comparative Safety and Pharmacokinetic Study of JHL1922 and Pulmozyme® in Healthy Subjects Healthy Subjects | Phase 1 | 2018-01-26 |
| Terminated | A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis Rheumatoid Arthritis, Arthritis, Rheumatoid | Phase 1 | 2017-02-27 |